Introduction
Arrythmogenic right ventricular dysplasia/cardiomyopathy (ARVD) is a familial cardiomyopathy characterised clinically by right ventricular (RV) dysfunction as well as ventricular tachycardia [1] [2] [3] [4] and histopathologically by fibro-fatty replacement of the myocardium. 5 Left ventricular (LV) involvement can occur and appears to correlate with increased disease severity. 3, 4 Owing to the complexity of the disease, Task Force Criteria for diagnosis of ARVD were drawn up in 1994 and revised in 2010. 6, 7 Cardiovascular magnetic resonance (CMR) findings are now included in the list of major and minor criteria and currently play an important role in establishing the diagnosis of ARVD (see Table  I ). CMR is extremely valuable for delineation of right ventricular (RV) anatomy and function as well as for characterising the composition of the RV wall, especially regarding the presence of fatty and/or fibrous tissue.
Case report
A 60-year-old woman with metabolic syndrome was referred to us with a history of chest pain, syncopy and palpitations. Her ECG revealed RV strain pattern and inverted T waves in leads V1, V2 and V3. Echocardiographically, her RV wall was thickened and echo-dense and measured 15 mm at the free wall. No definite family history of any specific cardiac abnormality was present. She was referred for a CMR scan to confirm the possible diagnosis of ARVD. The CMR examination was performed with a 1.5-T MR Imager (Philips Medical Systems) using a dedicated cardiac phased array coil. Bright blood cine imaging in the short axis, right ventricular outflow tract (RVOT) and 4 chamber planes were obtained. Black blood images were acquired in short axis and 4 chamber planes with and without fat suppression. Gadolinium was administered at a dose of 1 ml/10 kg (24 ml Omniscan, GE Healthcare) and perfusion sequences performed as well as late enhancement views (LE) in the short axis and 4 chamber planes.
Functional analysis was done utilising the short axis bright blood images. Global decreased contractility of the RV was recorded with the RV ejection fraction measuring 40%.
Diffuse fatty infiltration of the RV wall was clearly visible. The fatty infiltration mainly involved the sub-epicardium of the free wall of the RV (Figs 1-4) . Fatty infiltration was also visible in the right atrial free wall as well as the inter-atrial septum (Fig. 5) . The LV wall morphology and function was normal. No obvious late enhancement was noted. Cardiac catheterisation was undertaken, during which coronary angiography as well as endomyocardial biopsy were performed. Three specimens were taken from the RV free wall. All the coronary vessels appeared normal. Very mild elevated pulmonary arterial pressure was noted (34 mmHg/10 mmHg). Histological investigation revealed the presence of mature fatty tissue as well as fibrous tissue in the RV free wall biopsy specimens. The confirmed presence of fibrous tissue in addition to the marked fatty infiltration on histology suggested the possible diagnosis of ARVD.
Discussion
The term arrhythmogenic right ventricular dysplasia was first used by Frank et al. in 1978. 8 Marcus et al. were the first to note a familial occurrence of ARVD. 1 There are several genetic defects described that lead to an ARVD phenotype, but the exact pathogenesis is still under discussion. Hereditary occurrence in 30% of cases requires the assessment of relatives.
The wide spectrum of clinical presentations includes palpitations, tachy-arrhythmias, cardiac failure and sudden death. The condition is characterised by structural and functional abnormalities of the RV eventually leading to ventricular arrhythmias and progressive RV failure. Ventricular arrhythmias probably occur via the fibromuscular bundles being isolated from each other by fatty tissue, leading to re-entry phenomena. The RV sub-epicardial wall is initially replaced by fibro-fatty tissue often starting in the areas known as the 'triangle of dysplasia' , 1 i.e. the inferior tricuspid region, the RV outflow tract and the RV apical region. The fibro-fatty changes eventually progress to involve the whole RV wall trans-murally and globally. Although LV involvement may be found, the LV myocardium is usually spared. Until recently, the only accurate way to confirm the presence of fibrofatty changes involved endomyocardial biopsy. To lower potential risk, endomyocardial biopsies are usually obtained from the septum region (an area uncommonly affected), so resulting in a lowered sensitivity.
(Owing to the marked thickening of the RV wall, the biopsies in our patient could be taken from the free wall, without substantial risk).
The diagnosis of ARVD at its early stages remains a clinical challenge. No single test can be used to establish or exclude ARVD. CMR can assist substantially in the diagnosis of anatomical abnormalities and functional disturbances, as well as detecting the presence of fat or fibrous tissue once they occur.
CMR is superior to 2-D echocardiography in determination of RV mass and volume. CMR allows the acquisition of true short-axis images encompassing the entire RV with high spatial and temporal resolution, so providing highly accurate qualitative RV mass and functional data. Functional abnormalities can be detected on the bright blood cine sequences, and include global or regional hypokinesia resulting in reduced ejection fraction (EF) as well as increased RV volumes. The structural abnormalities occurring in ARVD include RV dilatation (localised or global bulging), right ventricular outflow tract (RVOT) enlargement, thinning of the RV wall (segmental or global) and aneurysm formation.
Fatty infiltration can be detected on the black blood T1-weighted images as well as the cine bright blood images. Fat visualisation on MRI has not been found to be specific for ARVD, however, 9,10 and there is poor inter-reader agreement on reporting of its presence and severity.
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Recently, the first observations of delayed enhancement of fibrotic tissue in patients with ARVD have been reported on. 12 Only two-thirds of the patients with ARVD showed delayed enhancement. The reason for the lack of delayed enhancement in the remainder may be the presence of a pure fatty form of ARVD or may simply reflect the insensitivity of current MRI techniques to detect a small amount of fibrosis in early disease. The emergence of techniques enabling us to quantify and refine the detection of localised or diffuse fibrosis will certainly help to improve the sensitivity. 13 Although the presence of fatty or fibrous tissue in the RV wall is not specific, it confirms the diagnosis in the presence of other criteria including a positive family history and specific ECG abnormalities.
Three of the major diagnostic criteria for ARVD according to the new Task Force Criteria were present in our patient, i.e. inverted T waves in V1-V3 on ECG, global hypokinesia of the RV (with increased RV volumes) and histologically proven fibro-fatty changes in the RV wall. The extensive amount of fatty infiltration and thickening of the RV wall in this patient are rare, however, and can possibly be attributed to her additional underlying metabolic abnormality and body habitus (the right atrial wall was also involved, underscoring this). There was a large amount of mediastinal and pericardial fat visible as well. Although all the necessary criteria for the diagnosis of ARVD were present in our patient, her existing metabolic disorder probably contributed to the severity of the fatty infiltration visible in the RV wall.
ARVD remains a difficult disorder to diagnose, but CMR has evolved to become a very valuable adjunctive diagnostic tool.
